Vibrissal sense is not the main sensory modality in rat exploratory behavior in the elevated plus-maze

Behavioural Brain Research

Volumn 122, Issue 2, 2001, Pages 169-174

  Cardenas, Fernando ^a   Lamprea, Marisol R ^a   Morato, Silvio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aversion; Elevated plus maze; Exploratory behavior; Information search; Rats; Sensory systems; Thigmotaxis; Vibrissa removal

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AVERSION; CONTROLLED STUDY; ENVIRONMENT; EXPLORATORY BEHAVIOR; ILLUMINATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; ROLE PLAYING; SENSORY SYSTEM; VIBRISSA; VISION;

ANIMALS; ANXIETY; EXPLORATORY BEHAVIOR; MALE; RATS; RATS, WISTAR; SENSATION; VIBRISSAE;

EID: 0035480583     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00180-2     Document Type: Article

References (52)

1. The role of vibrissae in behavior: a status review
2. Aversive stimulation and rats' preference for areas differing in novelty-value and brightness
3. Prenatal protein malnutrition affects exploratory behavior of female rats in the elevated plus maze test
4. The rat's right-left preference during free exploration of a multiple Y-maze
5. The effect of corticosterone in rats submitted to the elevated plus-maze and to pentylenetetrazol-induced convulsions
6. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls
7. Microinjections of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin
8. Illumination has no effect on rats' behavior in the elevated plus maze
9. Diazepam changes risk assessment in an anxiety/defense test battery
10. An ethoexperimental analysis of defense, fear and anxiety
11. Effects of serotoninergic lesions on 'anxious' behavior measured in the elevated plus-maze in the rat
12. Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission
13. Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe, lesions
14. Ethopharmacological analysis of rat behavior on the elevated plus maze
15. Severe anxiety induced by FG7142, a β-carboline for benzodiazepine receptors
16. Some critical determinants of the behavior of rats in the elevated plus maze
17. Species-specific behavior and acquisition of avoidance behavior in rats
18. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey
19. Exploration and fear in the rat
20. 5-HT drugs in animal models of anxiety
21. A review of the validity and variability of the elevated plus maze as an animal model of anxiety
22. Effects of illumination and handling upon rat open field activity
23. Intra-hippocampal buspirone in animal models of anxiety
24. Dissotiation of memory and anxety in a repeated elevated plus-maze paradigm.
25. The effect of fear and anxiety on exploration and curiosity
26. 1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus-maze test
27. Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates
28. The need to know and fear of knowing
29. Intra-hippocampal administration of cycloheximide attenuates the restraint-induced exploratory deficit of an elevated plus-maze
30. Paradoxical increase of exploratory behavior in the elevated plus maze by rats exposed to two kinds of aversive stimuli
31. Effects of floor surface and environmental illumination on exploratory activity in the elevated plus maze
32. An evaluation of the elevated plus maze test using the novel anxiolytic buspirone
33. 1A receptors on the exploratory activity of rats in the elevated plus-maze
34. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?
35. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus maze: a novel test of anxiety in the rat
36. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
37. The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines
38. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines
39. The elevated plus maze: pharmacology, methodology and ethology
40. Role of benzodiazepine receptors located in the dorsal periaqueductal grey in anxiety
41. Role of vibrissae for depth perception in the rat (Rattus novergicus)
42. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats
43. Strain differences in open-field and elevated plus-maze behavior of rats without and with pretest handling
44. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions
45. GABA immumoteactivity in mouse barrel field after aversive and appetitive classical conditioning training involving facial vibrissae.
46. Anxiety reduction and novelty as goals of visual exploration by monkeys
47. Thigmotaxis as a test for anxiolytic activity in rats
48. Anxiogenic stimuli in the elevated plus-maze
49. Dissociating the anti-fear effects of Septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety
50. Effects of strain, sex and illumination on open field behavior in rats
51. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze